by newsworm | Mar 12, 2025 | Lupin, Pharma
Lupin, a leading pharmaceutical company, has announced the launch of AjaDuo, a fixed-dose combination (FDC) of empagliflozin and linagliptin, at an affordable price. The launch is a significant development in the Indian pharmaceutical market, offering patients with... by newsworm | Mar 11, 2025 | Alkem, Lupin, Mankind, Pharma, Torrent Pharma
The cost of Empagliflozin, a crucial drug for managing diabetes and its associated conditions, is set to drop significantly in India. The price of the medicine, which was previously around Rs 60 per tablet, will be reduced to just Rs 9 per tablet, making it more... by newsworm | Mar 9, 2025 | Lupin, Pharma
Here is a 400-word summary of the content: Women’s health is a complex issue influenced by socioeconomic factors, cultural norms, and evolving healthcare landscapes. In India, young women face unique challenges, including nutritional deficiencies, reproductive... by newsworm | Mar 8, 2025 | Lupin, Pharma
Lupin, a global pharmaceutical company, has launched its anti-clotting drug Rivaroxaban in the US market. The company has received approval from the United States Food and Drug Administration (FDA) to market the medication, which is used to treat conditions such as... by newsworm | Mar 2, 2025 | Lupin, Pharma
Lupin, a global pharmaceutical company, has been selected to be included in the prestigious S&P Global Sustainability Yearbook 2025. This recognition is a testament to the company’s commitment to sustainability and its efforts to reduce its environmental... by newsworm | Mar 1, 2025 | Lupin, Pharma
The Bombay High Court has cancelled the notice of income tax reassessment sent to Lupin Limited for the financial year 2016-17. The company had filed its tax return, showing an income of Rs. 2,636 crore, and had claimed deductions for CSR expenses under Sections 35AC...